Lecozotan

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Template:Short description Template:Cs1 config Template:Drugbox

Lecozotan is an investigational drug by Wyeth tested for improvement of cognitive functions of Alzheimer's disease patients.[1] since June 2008Template:Dated maintenance category (articles)Script error: No such module "Check for unknown parameters"., the first Phase III clinical trial has been completed.[2]

Method of action

Lecozotan is a competitive, selective 5-HT1A receptor antagonist[3] which enhances the potassium-stimulated release of acetylcholine and glutamate.[4]

References

<templatestyles src="Reflist/styles.css" />

  1. Script error: No such module "Citation/CS1".
  2. ClinicalTrials
  3. Script error: No such module "Citation/CS1".
  4. Script error: No such module "Citation/CS1".

Script error: No such module "Check for unknown parameters".

Template:Antidementia

Template:Serotonergics


Template:Nervous-system-drug-stub